Urology Times Innovation Celebration Video Series - Episode 16
"I would say our greatest advance of the past 30 years is our clinical trials infrastructure, because we can now use our therapies with intelligence," says Anthony Zietman, MD.
Urology Times® is celebrating its 50th anniversary in 2022. To mark the occasion, we are high-lighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, Anthony Zietman, MD, discusses the development of radia-tion therapy for prostate cancer. Zietman is interim chief of Radiation Oncology at Massachusetts General Hospital in Boston and has recently retired as Editor-in-Chief of the International Journal of Radiation Oncology Biology Physics (The “Red Journal”).